CSL PHARMA-ADVICE ApS: Financial statements 2022
CVR: 36501693
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CSL PHARMA-ADVICE ApS (CVR 36501693) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890. The solvency ratio was 95.3%.
- Revenue
- DKK 0
- Gross Profit
- DKK 30,604
- Profit/Loss
- DKK 32,496
- Equity
- DKK 133,890
- Total Assets
- DKK 140,520
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | 31 t. | 32 t. | 134 t. | - |
| 2021 | 0 | -35 t. | -45 t. | 266 t. | - |
| 2020 | 143 t. | 95 t. | 71 t. | 421 t. | - |
| 2019 | 261 t. | 181 t. | 135 t. | 480 t. | - |
| 2018 | 400 t. | 281 t. | 214 t. | 546 t. | - |
Official annual report
Keep an eye on CSL PHARMA-ADVICE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CSL PHARMA-ADVICE ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -44,528.
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS was a Danish company of the type Anpartsselskab based in Lejre, founded in 2015. The company has been dissolved on 4 January 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890.